Ahead of the earnings release, Wall Street analysts expect its bottom line to grow. Analysts expect Insulet to report a ...

Insulet estimated that its total addressable market for automated insulin delivery will grow to a $9bn market value by 2028.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.

Image from Insulet website] BVI announced today that it appointed Jim Hollingshead as its new president and CEO. Hollingshead ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it will report financial ...

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Following a robust ...

This was the stock's fifth consecutive day of losses.

5 analysts have shared their evaluations of Insulet (NASDAQ:PODD) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table encapsulates their recent ...

Insulet has named two employees to new C-suite roles shortly after the Acton-based medical device manufacturer became the sole Central Massachusetts public company to be led by a woman earlier this ...

After receiving a jury verdict awarding $452 million in damages against a rival company for misappropriation of trade secrets, the prevailing party, Insulet Corp., may have to choose between portions ...